Clinical trial
Lemborexant Treatment of Insomnia Linked to Epilepsy
NCT06262594 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lemborexant Treatment of Insomnia Linked to Epilepsy
- Lead sponsor
- University of Manitoba
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 29, 2024
- Completion date
- April 18, 2027
- Enrollment
- 26 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy, sleep